Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uniklinik Dresden
Dresden, Germany
- Universitaetsklinikum Essen
Essen, Germany
- Asklepios Kliniken Altona
Hamburg, Germany
- Universitätsmedizin Mannheim
Mannheim, Germany
- Städtisches Klinikum München
München, Germany
- Asst Grande Ospedale Metropolitano Niguarda
Milan, Italy
- Istituto Nazionale Tumori Irccs "fondazione G. Pascale"
Naples, Italy
- Università Degli Studi Della Campania "luigi Vanvitelli"
Naples, Italy
- Hospital del Mar
Barcelona, Spain
- Institut Català D'Oncologia
Barcelona, Spain
- Vall D'Hebron Institut D'Oncologia (vhio)
Barcelona, Spain
- Hospital Universitario Hm Sanchinarro
Madrid, Spain
- Hospital Clínico de Valencia
Valencia, Spain
- City of Hope - Comprehensive Cancer Center
Duarte, California, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of North Carolina - Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Nov 2018
- Primary completion
- 1 Mar 2019
- Completion
- 9 Mar 2019
- Last update posted
- 28 Sept 2020
- Registered enrollment
- 2
- Registry id
- NCT03549338
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.